Photodynamic therapy of the ciliary body with tin ethyl etiopurpurin and tin octaethyl benzochlorin in pigmented rabbits

Ophthalmic Surgery and Lasers

Volumn 28, Issue 11, 1997, Pages 948-953

  Hill, Richard A ^a   Crean, David H ^c   Doiron, Daniel R ^c   Ghosheh, Faris ^a   Ryan, Julie A ^a   Kelly, Heath ^c   Booth, Michael ^a   Liaw, Lih Huei ^a,b   Newman, Laurie ^a   Berns, Michael W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PDT Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BNZ 203; ETIOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; SNET 2; TIN ETHYLETIOPURPURIN; TIN OCTAETHYLBENZOCHLORIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CILIARY BODY; CONTROLLED STUDY; DRUG DISTRIBUTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT;

ANIMALS; CILIARY BODY; DEUTEROPORPHYRINS; EPITHELIUM; LASERS; MICROSCOPY, FLUORESCENCE; ORGANOTIN COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RABBITS;

EID: 0030725465     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Klapper RM, Wandel T, Donnenfeld E, Perry HD. Transscleral neodymium:YAG thermal cyclophotocoagulation in refractory glaucoma. Ophthalmology. 1988;95:719-722.
2. Trope GE, Ma S. Mid-term effects of neodymium:YAG transscleral cyclocoagulation in glaucoma. Ophthalmology. 1990;97:73-75.
3. Hampton C, Shields MB, Miller KN, Blasini M. Evaluation of a protocol for transscleral neodymium:YAG cyclophotocoagulation in one hundred patients. Ophthalmology. 1990;97:910-917.
4. Shields MB, Shields SE. Noncontact transscleral Nd:YAG cyclophotocoagulation: a long term follow-up of 500 patients. Trans Am Ophthalmol Soc. 1994;92:271-287.
5. Schuman JS, Bellows AR, Shingleton BJ, et al. Contact transscleral Nd:YAG laser cyclophotocoagulation: midterm results. Ophthalmology. 1992;89:210-217.
6. Schuman JS, Puliafito CA, Allingham RR, et al. Contact transscleral Nd:YAG laser cyclophotocoagulation. Ophthalmology. 1990;97:571-580.
7. Gomer CJ, Doiron DR, White L, et al. Hematoporphyrin derivative photoradiation induced damage to normal and tumor tissue of the pigmented rabbit eye. Curr Eye Res. 1984;3:229-237.
8. Hill RA, Esterowitz T, Ryan J, et al. Photodynamic therapy (PDT) of the ciliary body with Photofrin II (PII) and chloroaluminum sulfonated phthalocyanine (CASPc) in Dutch cross rabbits. Lasers Surg Med. 1995;17:166-171.
9. Hill RA, Garret J, Reddi S, et al. Photodynamic therapy of the ciliary body with silicon naphthalocyanine (SiNc) in rabbits. Lasers Surg Med. 1996;18:86-91.
10. Tsilimbaris MK, Naoumidi II, Naoumidis LP, Papageorgiou E, Pallikaris IG. Transscleral ciliary body photodynamic therapy using phthalocyanine and a diode laser: functional and morphologic implications in albino rabbits. Ophthalmic Surg Lasers. 1997; 28:483-494.
11. Gomer CJ, Rucker N, Ferrario A, Wong S. Properties and applications of photodynamic therapy. Radiat Res. 1989;120:1-18.
12. Henderson BW, Dougherty TJ. How does photodynamic therapy work? J Photochem Photobiol B. 1992; 55:145.
13. Wilson BC, Patterson MS. The physics of photodynamic therapy. Phys Med Biol. 1986;31:327.
14. Spikes JD. Phthalocyanines as sensitizers in biological systems and for the photodynamic therapy of tumors. Photochem Photobiol. 1986;43:691-699.
15. Milanesi C, Biolo R, Reddi E, et al. Ultrastructural studies on the mechanism of the photodynamic therapy of tumors. Photochem Photobiol. 1987;46:675-681.
16. Ben-Hur E, Green M, Prager A, et al. Phthalocyanine photosensitization of mammalian cells: biochemical and ultrastructural effects. Photochem Photobiol. 1987; 46:651-656.
17. Ben-Hur E, Rosenthal I. Factors affecting the photokilling of cultured Chinese hamster cells by phthalocyanines. Radiat Res. 1985;103:403-409.
18. Nelson JS, Liaw L-H, Orenstein A, et al. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J Natl Cancer Inst. 1988;80: 1599-1605.
19. Vogel A, Dlugos C, Nuffer R, et al. Optical properties of human sciera and their consequences for transscleral laser applications. Lasers Surg Med. 1991;11:331-340.
20. Baumal CR, Puliafito CA, Pieroth L, et al. Photodynamic therapy (PDT) of experimental choroidal neovascularization with tin ethyl etiopurpurin. Invest Ophthalmol Vis Sci. 1996;37(suppl):122.
21. Crean DH, Peyman GA, Moshfeghi DM, et al. Photodynamic therapy response of choriocapillaris using tin ethyl etiopurpurin (SnET2). Invest Ophthalmol Vis Sci. 1996;37(suppl):122.
22. Hill RA, Ghosheh F, Kim JJ, et al. Photodynamic cyclodestruction in pigmented rabbits using tin ethyl etiopurpurin (SnET2). Invest Ophthalmol Vis Sci. 1996;37(suppl):408.
23. Hill RA, Crean DH, Doiron DR, et al. Photodynamic therapy (PDT) for antifibrosis in a rabbit model of filtration surgery. Invest Ophthalmol Vis Sci. 1995; 36(suppl):877.
24. Razum NJ, Snyder AB, Doiron DR. SnET2 clinical update: optical methods for treatment and detection: mechanisms and techniques in photodynamic therapy V. SPIE Proceedings. 1996;2675:43-46.
25. Morgan AR, Skalkos D, Maguire G, et al. Observations on the synthesis and in vivo photodynamic activity of some benzochlorins. Photochem Photobiol. 1992; 55:133-136.
26. Kessel D, Morgan A. Photosensitization with etiobenzochlorins and octaethylbenzochlorins. Photochem Photobiol. 1993;58:521-526.
27. Hill RA, Crean DH, Doiron DR, et al. Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery. Ophthalmic Surg Lasers. 1997;28:574-581.